Abstract:Combination delivery systems composed of injectable hydrogels and drug-incorporated micelles or nanoparticles with tunable and convenient properties for clinical operation and storage are urgently demanded in regional cancer chemotherapy to prolong and control drug release, enhance antitumor efficiency and decrease side effects. Previously, we developed a novel thermosensitive amphiphilic triblock copolymer, poly(epsilon-caprolactone-co-1,4,8-trioxa[4.6]spiro-9-undecanone)-poly(ethylene glycol)-poly( epsilon-caprolactone-co-1,4,8-trioxa[4.6] spiro-9-undecanone) (PECT), and fabricated a reconstituted "two into one" combination system of thermosensitive injectable hydrogel PTX/PECTGel, assembled from paclitaxel (PTX)-loaded PECT nanoparticles (NPs). PTX/PECTGel could be stored as freeze-dried powders of paclitaxel-loaded PECT NPs, which could be reconstituted into aqueous fluid dispersions at ambient temperature just by mixing with water after gentle stirring for several minutes, and form a hydrogel at the injected site in vivo. Herein, the drug release, in vivo morphology, antitumor efficiency and pharmacokinetic properties of PTX/PECTGel were evaluated. The PTX/PECTGel combination system could continuously release PTX in a near linear manner over 42 days in vitro, and simultaneously, PTX/PECT NPs containing 75% of the total released PTX could dissociate from the PTX/PECTGel. PTX/PECTGel exhibited remarkable in vitro anti-proliferative activities against Ehrlich ascites carcinoma (EAC) cancer cells. The peritumorally or intratumorally injected PECT gel could cover the entire surface or fill up the interior space of the tumor, respectively. A single peritumoral injection of the PTX/PECTGel formulation at a low dosage of 10 mg kg(-1) could completely inhibit the growth of an EAC tumor inoculated in Balb/c mice after the first week, and the inhibition could be sustained for more than 21 days. The plasma pharmacokinetic study demonstrated that PTX/PECTGel could greatly decrease the systemic exposure of PTX, as confirmed by the rather low plasma concentration. On the other hand, the PTX concentration in normal tissues with the intratumoral injection of PTX/PECTGel was approximately 2 mu g g(-1), which was 3-10 times lower than that with the intraperitoneal or intratumoral injection of Taxol (R), implying fewer off-target side effects. These data confirmed that the PTX/PECTGel combination local delivery system could vastly prolong the in vitro and in vivo paclitaxel release, enhance the local tumor inhibition effect and lower the systemic exposure and tissue distribution of paclitaxel. Hence, the "two into one" PTX/PECTGel system holds underlying value for regional cancer chemotherapy.

Paclitaxel-PECT in Situ Gel Anti Tumor Effect of Preliminary Evaluation

[Preparation and Characterization of Paclitaxel Microspheres in Situ Gel and Its Antitumor Efficacy by Local Injection].

Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer

A reconstituted "two into one" thermosensitive hydrogel system assembled by drug-loaded amphiphilic copolymer nanoparticles for the local delivery of paclitaxel

Orthogonal Preferred Injectable Gel Containing Drug-loaded Taxol/PECT in Vivo Anti-tumor Effect of Dosage Regimen

A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy.

Development And Evaluation Of A Novel Tpgs-Mediated Paclitaxel-Loaded Plga-Mpeg Nanoparticle For The Treatment Of Ovarian Cancer

A comparative investigation between paclitaxel nanoparticle- and nanocrystal-loaded thermosensitive PECT hydrogels for peri-tumoural administration.

Preparation and Anti-Tumor Activity of Paclitaxel Thermo-Sensitive Hydrogel

Efficient Antitumor Effect of Co-Drug-loaded Nanoparticles with Gelatin Hydrogel by Local Implantation

Preparation of thermosensitive liposomes containing paclitaxel and their anticancer effect

An injectable thermosensitive hydrogel self-supported by nanoparticles of PEGylated amino-modified PCL for enhanced local tumor chemotherapy

Preparation of a Thermosensitive Gel Composed of a Mpeg-Plga-pll-crgd Nanodrug Delivery System for Pancreatic Tumor Therapy

The Anti-Tumor Effects of Lung Cancer-Targeting Long-Circulating Paclitaxel-Containing Liposomes

The tissue distribution and antitumor effect of nano-paclitaxel injection in tumor-bearing mice

Thermosensitive Hydrogel System Assembled by PTX-loaded Copolymer Nanoparticles for Sustained Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis.

Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity

P204 A paclitaxel–cisplatin loaded thermosensitive hydrogel for in situ treatment of lung cancer

The Inhibitory Effect of Paclitaxel Nanoparticles on Ovarian Cancer Xenografts and Lymphatic Targeting

Toxicity Andin Vivobiological Effect of the Nanoparticular Self-Supported Hydrogel of a Thermosensitive Copolymer for Non-Invasive Drug Delivery

Targeting Therapy with Docetaxel Thermosensitive Nano-Micelles of Human Gastric Cancer Xenografts in Nude Mice